Skip to main content
. 2020 Mar 6;18:118. doi: 10.1186/s12967-020-02286-z

Fig. 4.

Fig. 4

Kaplan–Meier analyses of LUAD patients with stage, KRAS mutation status, and EGFR mutation status, including a stage 3–4, b stage 1–2, c KRAS mutation, d KRAS wild-type, e EGFR mutation, and f EGFR wild-type